SCHEMBL166350

SCHEMBL166350

CC(C)(C)OC(=O)NCC(C(=O)Nc1ccc2cnccc2c1)c1ccc(OC(=O)C2(CI)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 20/20 0.55
ROCK1 Q13464 2/20 0.45
MYLK4 Q86YV6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL174051 0.91 ROCK2 (0.58) ROCK2ROCK1MYLK4
SCHEMBL9883178 0.85 ROCK2 (0.74) ROCK2ROCK1MYLK4
SCHEMBL30279716 0.83 ROCK2 (0.66) ROCK2ROCK1MYLK4
SCHEMBL2779487 0.83 ROCK2 (0.66) ROCK2ROCK1MYLK4
SCHEMBL17993613 0.83 ROCK2 (0.66) ROCK2ROCK1MYLK4
SCHEMBL19932324 0.83 ROCK2 (0.57) ROCK2ROCK1MYLK4
SCHEMBL21774980 0.83 ROCK2 (0.57) ROCK2ROCK1MYLK4
SCHEMBL21774940 0.83 ROCK2 (0.57) ROCK2ROCK1MYLK4
SCHEMBL16040565 0.83 ROCK2 (0.66) ROCK2ROCK1MYLK4
SCHEMBL31296116 0.83 ROCK2 (0.66) ROCK2ROCK1MYLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424842-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2012-03-07 EP disclosed
WO-2010126626-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE AERIE PHARMACEUTICALS, INC. (US) 2010-11-04 WO disclosed